首页> 外文OA文献 >Genetic variability of the core protein in hepatitis C virus genotype 4 in Saudi Arabian patients and its implication on pegylated interferon and ribavirin therapy

【2h】

Genetic variability of the core protein in hepatitis C virus genotype 4 in Saudi Arabian patients and its implication on pegylated interferon and ribavirin therapy

机译：沙特阿拉伯患者丙型肝炎病毒基因型4中核心蛋白的遗传变异性及其对聚乙二醇化干扰素和利巴韦林治疗的意义

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Fatimah S Alhamlan; Mohammed N Al-Ahdal; Nisreen Z Khalaf; Ayman A Abdo; Faisal M Sanai; Hamad I Al-Ashgar; Mahmoud ElHefnawi; Amina Zaid; Ahmed A Al-Qahtani;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Genetic variability of the core protein in hepatitis C virus genotype 4 in Saudi Arabian patients and its implication on pegylated interferon and ribavirin therapy [J] . Fatimah S Alhamlan, Mohammed N Al-Ahdal, Nisreen Z Khalaf, Journal of Translational Medicine . 2014,第1期

机译：沙特阿拉伯患者丙型肝炎病毒基因型4中核心蛋白的遗传变异性及其对聚乙二醇化干扰素和利巴韦林治疗的意义
2. Hepatitis C virus genotype 1: How genetic variability of the core protein affects the response to pegylated-interferon and ribavirin therapy [J] . AlhamlanF.S., Al-AhdalM.N., KhalafN.Z., Journal of Medical Virology . 2014,第2期

机译：丙型肝炎病毒基因型1：核心蛋白的遗传变异性如何影响对聚乙二醇化干扰素和利巴韦林治疗的反应
3. Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy. [J] . Akuta N, Suzuki F, Kawamura Y, Journal of Medical Virology . 2008,第8期

机译：小剂量间歇性干扰素-α单一疗法对被预测为或对聚乙二醇化干扰素加利巴韦林联合治疗无效的丙型肝炎病毒基因型1b感染的患者的疗效。
4. Studies of Therapy with Thymosin α 1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C [C] . ROBERTO CAMERINI, ALESSIA CIANCIO, ALFONSO DE ROSA, International Symposiumn on Thymosins in Health and Disease; 20070321-24; Washington,DC(US) . 2007

机译：胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
5. The meaning of adherence among veterans receiving pegylated interferon and ribavirin antiviral treatment for chronic hepatitis C. [D] . Phillips, Frances Hinshaw. 2011

机译：接受聚乙二醇干扰素和利巴韦林抗病毒治疗的慢性丙型肝炎退伍军人依从性的含义。
6. Genetic variability of the core protein in hepatitis C virus genotype 4 in Saudi Arabian patients and its implication on pegylated interferon and ribavirin therapy [O] . Fatimah S Alhamlan, Mohammed N Al-Ahdal, Nisreen Z Khalaf, 2014

机译：沙特阿拉伯患者丙型肝炎病毒基因型4中核心蛋白的遗传变异性及其对聚乙二醇化干扰素和利巴韦林治疗的意义
7. Secreted Phosphoprotein 1 Promoter Genetic Variants Are Associated with the Response to Pegylated Interferon α Plus Ribavirin Combination Therapy in Egyptian Patients with Chronic Hepatitis C Virus Infection [O] . Fahmy T Ali, Mohamed A M Ali, Mayada M A Elgizawy, 2015

机译：分泌的磷蛋白1启动子遗传变异与埃及慢性丙型肝炎病毒感染患者对Pegymated干扰素α加的助剂致答复相关

Genetic variability of the core protein in hepatitis C virus genotype 4 in Saudi Arabian patients and its implication on pegylated interferon and ribavirin therapy

著录项

引文网络

相似文献

相关主题

期刊订阅